Post-market single center experience with a subcutaneous auto-injector of testosterone enanthate (Xyosted)
Main Authors: | P. Xu, E. Choi, F.M. El-Khatib, F.A. Yafi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320326288 |
Similar Items
-
Polycystic Ovary Induction in Mouse by Testosterone Enanthate
by: Zahra Kalhori, et al.
Published: (2014-03-01) -
Pharmacokinetic Profile of Subcutaneous Testosterone Enanthate Delivered via a Novel, Prefilled Single‐Use Autoinjector: A Phase II Study
by: Jed Kaminetsky, MD, et al.
Published: (2015-12-01) -
The Effect of Repaglinide on Polycystic Ovary Induced by Testosterone Enanthate in NMRI Mice
by: Fariba Noori, et al.
Published: (2017-02-01) -
Azoospermia and severe oligozoospermia in Indonesian men following injections with testosterone enanthate or 19-nortestosterone plus progestogen
by: Nukman Moeloek
Published: (1996-07-01) -
Physical and Psychological Effects of Gender-Affirming Hormonal Treatment Using Intramuscular Testosterone Enanthate in Japanese Transgender Men
by: Takahiro Kirisawa, MD, et al.
Published: (2021-04-01)